USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Industries
Subscribe to RSS Feed-
15 Jul 2024 | Global | Technology Research
Connected Diabetes Care: Innovations and Growth Opportunities
Continuous Glucose Monitoring, Artificial Pancreas Systems, and Novel Insulin Delivery Formulations to Transform the Future of Diabetes Management
The preference for diabetes self-assessment using wearable CGMs instead of finger-stick blood sugar testing is increasing, especially in type 1 diabetics (T1D). HbA1c and time-in-range are currently the preferred biomarkers for diabetes monitoring applications. Emerging diet and fitness tracking apps help support general well-being and prevent the ...
$4,950.00
Special Price $3,712.50 save 25 %
-
12 Jun 2024 | Global | Market Research
Innovative AI-enabled Clinical Trial Companies: Strategic Profiling and Growth Opportunities
The Integration of Real-world Insights into Trial Management is Propelling AI Adoption in Clinical Trials
As global clinical pipelines witness a surge in complex novel therapies, there is a general inclination toward improving trial design through adaptive trial designs with technology-enabled solutions for planning and execution. Artificial intelligence (AI) is gaining large-scale recognition in terms of supporting decentralized trial designs and allo...
$2,450.00
Special Price $1,837.50 save 25 %
-
01 Mar 2024 | North America | Market Research
Global Orphan Drug Growth Opportunities
Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions
In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...
$4,950.00
Special Price $3,712.50 save 25 %
